Takeda and GSK win Pharma Marketing award
GlaxoSmithKline and the UK subsidiary of of Takeda are joint winners ofthe of the Pharmaceutical Company of the Year award, made annually in the UK by the journal Pharmaceutical Marketing.
Commenting on their choice of Takeda, the judges said that the company "should be rewarded for being a small company up against many big companies and doing an excellent job." Takeda is Japan's largest pharmaceutical company but on the international front is way behind the might of GSK, the world's second-largest drugmaker. Andy Davis, managing director of Takeda UK, expressed his pleasure at the award and said that he was now looking forward, with his team, to building on this success and that of its products, notably Actos (pioglitazone) and Amias (candesartan).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze